 | Gail M. Wilkes - 2004 - 1146 páginas
...Kinase Inhibitor, in Patients with Advanced Solid Malignancies. J Clin Oncol 2001;19(13):3267-3279 Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab...leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350(23): 2335-2342 Imclone Systems, Erbitux package insert. NY.Imclone Systems, Inc. 2004 Keating... | |
 | Bernard Levin, Paul Rozen, Stephen J. Spann, Graeme P. Young - 2005 - 200 páginas
...irinotecan in irinotecan-refactory metastatic colorectal cancer. N Engl J Med 2004; 351: 337-45. 54. Hurwitz H, Fehrenbacher L, Novotny W et al, Bevacizumab...leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-42. 55. Berman JM, Chenng RJ, Weinberg DS, Surveillance after colorectal cancer resection.... | |
 | Alfred E. Chang, Patricia A. Ganz, Daniel F. Hayes, Timothy Kinsella, Harvey I. Pass, Joan H. Schiller, Richard M. Stone, Victor Strecher - 2007 - 2012 páginas
...biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors 1992;7(1):53-64. 104. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab...leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350(23):2335-2342. 105. Johnson DH, Fehrenbacher L, Novotny WF, et al. Randomized phase II trial... | |
 | William J. LaRochelle, Richard A. Shimkets - 2007 - 750 páginas
...monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 1997; 57:4593-4599. 7. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab...leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350:2335-2342. 8. Kabbinavar F, Hurwitz HI, Fehrenbacher L, et al. Phase II, randomized trial... | |
 | Jame Abraham, James Leonard Gulley, Carmen J. Allegra - 2005 - 728 páginas
...and novel analyses from two large, randomised, phase III trials. BrJ Cancer 2004;90: 1 190-1 197. 25. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab...leucovorin for metastatic colorectal cancer. N Engl J Afe/ 2004;350:2335-2342. 26. Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab... | |
 | Kyle Holen, Ki Young Chung - 2008 - 100 páginas
...Biology of angiogenesis in tumors of the gastrointestinal tract. Microsc Res Tech. 2003-.60: 199-207. 25. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab...leucovorin for metastatic colorectal cancer. N Engl] Med. 2004;350:2335-2342. 26. Giantonio BJ, Catalano PJ, Meropol NJ, et al. High-dose bevacizumab in... | |
 | Michel Boiron, Michel Marty - 2005 - 394 páginas
...endothelial growth factor pathway in tumor growth and angiogenesis. ] Clin Oncol 2005 ; 23 : 101 1-27. 3. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab...and leucovorin for metastatic colorectal cancer. N Eng/ } Med 2004 ; 350 : 2335-42. 4. Kabbinavar F, Hurwitz HI, Fehrenbacher L, et al. Phase II, randomized... | |
 | Edward Chu - 2004 - 548 páginas
...irinotecan in irinotecan-refractory metastatic colorectal cancer (MCRC). N EnglJ Afoi 2004;35:337. 70. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab...and leucovorin for metastatic colorectal cancer. N EnglJ Afei 2004;350:2335. Chemothempeutic and Biologic Drugs Edward Chu, Augusto Mota, Michael Bromberg,... | |
 | Leon P. Bignold - 2006 - 396 páginas
...Novotny W. Cartwright T. Hainsworth J. Heim W, Berlin J, Baron A. Griffing S. Holmgren E et al. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335-2342 268 Kim KJ, Li B, Winer J, Armanini M, Gillett N. Phillips HS, Ferrara N (1993) Inhibition... | |
 | Franciscus Petrus Nijkamp, Michael J. Parnham - 2005 - 166 páginas
...Novotny W Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335-2342 100 Robert EEzekiel MP, Spencer SA, Meredith REBonner JA, Khazaeli MB, Saleh MN, Carey... | |
| |
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. 
